Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses

Veterinary Immunology and Immunopathology

Volumn 59, Issue 3-4, 1997, Pages 239-251

  Sheoran, Abhineet S ^a   Sponseller, Beatrice T ^b   Holmes, Mark A ^c   Timoney, John F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Commercial vaccine; IgA; IgG subisotypes; Mucosal immune response; SeM; Streptococcus equi

Indexed keywords

ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; M PROTEIN; STREPTOCOCCUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; HORSE; HOST RESISTANCE; INTRAMUSCULAR DRUG ADMINISTRATION; MUCOSAL IMMUNITY; NONHUMAN; NOSE SMEAR; OPSONIZATION; PHAGOCYTOSIS; STREPTOCOCCUS EQUI; VACCINATION;

EID: 0031422852     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(97)00074-3     Document Type: Article

References (51)

1. Aase, A., Michaelsen, T.E., 1994. Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Scand. J. Immunol. 39, 581-587.
2. Anonymous, 1981. Subcommittee on the Efficacy of Strangles Bacterin. Annual Conference of the American Association of Equine Practitioners. November 1981, New Orleans.
3. Banks, K.L., McGuire, T.C., 1975. Surface receptors on neutrophils and monocytes from immunodeficient and normal horses. Immunology 28, 581-588.
4. Barrett, D.J., Ayoub, E.M., 1986. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin. Exp. Immunol. 63, 127-134.
5. Bazely, P.L., 1942. Studies with equine streptococci: IV. Cross immunity to Streptococcus equi. Aust. Vet. J. 18, 189-197.
6. Boschwitz, J.F., Timoney, J.F., 1994. Inhibition of C3 deposition on Streptococcus equi subsp. equi by SeM: a mechanism of survival in equine blood. Infect. Immun. 62, 3515-3520.
7. Bryant, S., Brown, K.K., Lewis, S., Stewart, R.C., Parezik, R., 1985. Protection against strangles with an enzymatic Streptococcus equi extract. Vet. Med., September, 58-70.
8. Burton, D.R., Woof, J.M., 1992. Human antibody effector function. Adv. Immunol. 51, 1-84.
9. Fox, E.N., 1974. M proteins of group A streptococci. Bacteriol. Rev. 38, 51-86.
10. Galan, J.E., Timoney, J.F., 1985. Mucosal nasopharyngeal immune responses of horses to protein antigens of Streptococcus equi. Infect. Immun. 47, 623-628.
11. Galan, J.E., Timoney, J.F., 1987. Molecular and genetic analysis of the M-protein of Streptococcus equi. In: Ferretti, J.J., Curtiss, R. (Eds.), Streptococcal genetics. American Society for Microbiology, Washington, DC, pp. 181-184.
12. Galan, J.E., Timoney, J.F., 1988. Immunologic and genetic comparison of Streptococcus equi isolates from the United States and Europe. J. Clin. Microbiol. 26, 1142-1146.
13. Hamlen, H.J., Timoney, J.F., Bell, R.J., 1994. Epidemiologic and immunologic characteristics of Streptococcus equi infection in foals. J. Am. Vet. Med. Assoc. 204, 768-775.
14. Hoffman, A.M., Staempfli, H.R., Prescott, J.F., Viel, L., 1991. Field evaluation of a commercial M-protein vaccine against Streptococcus equi infection in foals. Am. J. Vet. Res. 52, 589-592.
15. Hussein, A.M., Newby, T.J., Bourne, F.J., 1983. Quantitation and origin of immunoglobulins A, G and M in the secretions and fluids of the reproductive tract of the sow. J. Reprod. Immunol. 5, 17-26.
16. Jean-Francois, M.J.B., Poskitt, D.C., Turnbull, S.J., McDonald, L.M., Yasmeen, D., 1991. Protection against Streptococcus equi infection by monoclonal antibodies against an M-like protein. J. Gen. Microbiol. 137, 2125-2133.
17. Jefferis, R., Kumararatne, D.S., 1990. Selective IgG deficiency: quantification and clinical relevance. Clin. Exp. Immunol. 81, 357-367.
18. Johnson, P.R., Feldman, S., Thompson, J.M., Mahiney, J.D., Wright, P.F., 1986. Immunity to influenza A infection in young children: a comparison of natural infection, live intranasal cold-adapted vaccine, and inactivated intramuscular vaccine. J. Infect. Dis. 154, 121-127.
19. Jorm, L.A., 1990. Strangles in horse studs: incidence, risk factors and effect of vaccination. Aust. Vet. J. 67, 436-439.
20. Jorm, L.R., Love, D.N., Bailey, G.D., 1994. Genetic structure of populations of β-haemolytic Lancefield group C streptococci from horses and their association with disease. Res. Vet. Sci. 57, 292-299.
21. Lancefield, R.C., 1959. Persistence of type specific antibodies in man following infection with group A streptococci. J. Exp. Med. 110, 271.
22. Mair, T.S., Stokes, C.R., Bourne, F.J., 1988. Immunohistochemical study of the local humoral immune system of the equine respiratory mucosa. Res. Vet. Sci. 45, 160-165.
23. McGuire, T.C., Crawford, T.W., Henson, J.B., 1973. The isolation, characterisation and functional properties of equine immunoglobulin classes and subclasses. In: Bryans, J.T., Gerber, H. (Eds.), Proceedings of the Third International Conference on Equine Infectious diseases. Karger, Paris, Basel, pp. 364-381.
24. Mestecky, J., McGhee, J.R., 1992. Prospects for human mucosal vaccines. Adv. Exp. Med. Biol. 327, 13-23.
25. Moore, B.T., Bryans, J.T., 1970. Type specific antigenicity of group C streptococci from diseases of the horse. In: Bryans, J.T., Gerber, H. (Eds.), Proceedings of the Second International Conference on Equine Infectious diseases. Karger, Paris, Basel, pp. 231-238.
26. Morell, A., Roth-Wicky, B., Skvaril, F., 1983. Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect. Immun. 39, 565-568.
27. Mortimer, G.E., Widdowson, J.P., 1979. Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein. Clin. Exp. Immunol. 37, 247-258.
28. Mulcahy, G., Gale, C., Robertson, P., Iyisan, S., DiMarchi, R.D., Doel, T.R., 1990. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 8, 249-256.
29. Nelson, K., Olsen, C.W., Schram, B.R., McGregor, M.W., Hinshaw, V.S., Lunn, D.P., 1995. Antibody isotypes and protection induced by influenza virus infection versus vaccination. In: Gershwin, L., Lunney, J., Schore, C., (Eds.), Proceedings of Fourth International Veterinary Immunology Symposium. University of California, Davis, 261 pp.
30. Nesch, B., 1996. Epizootiologische, klinische und immunologische Merkmale einer experimentell erzeugten Druse-Epizootie. Thesis, Freie Universitat Berlin, Berlin, Germany.
31. Ogra, P.L., Karzon, D.T., Righthand, F., Macgillivray, M., 1968. Immunoglobulin response in serum and secretions after immunization with live and inactivated polio vaccine and natural infections. N. Engl. J. Med. 279, 893-900.
32. Ogra, P.L., Chiba, Y., Beutner, K.R., Morag, A., 1976. Vaccination by non-parenteral routes: characterization of immune response. Dev. Biol. Stand. 33, 19-26.
33. Pahud, J.J., Mach, J.P., 1972. Equine secretory IgA and secretory component. Int. Arch. Allergy 42, 175-186.
34. Rainard, P., 1992. Isotype antibody response in cows to Streptococcus agalactiae group B polysaccharide-ovalbumin conjugate. J. Clin. Microbiol. 30, 1856-1862.
35. Rits, M., Hiemstra, P.S., Bazin, H., Van Es, L.A., Vaerman, J.-P., Daha, M.R., 1988. Activation of rat complement by soluble and insoluble rat IgA immune complexes. Eur. J. Immunol. 18, 1873-1880.
36. Sheoran, A.S., 1996. Characterisation of the subisotypes of equine IgG. Ph.D. Thesis, University of Cambridge, Cambridge, UK.
37. Sheoran, A.S., Holmes, M.A., 1996. Separation of equine IgG subclasses (IgGa, IgGb and IgG(T)) using their differential binding characteristics for staphylococcal protein A and streptococcal protein G. Vet. Immunol. Immunopathol. 55, 33-43.
38. Slack, J., Der-Balian, G., Nahm, M.H., Davie, J.M., 1980. Subclass restriction of murine antibodies: II. The IgG plague forming response to thymus-independent type 1 and type 2 antigen in normal mice and mice expressing an X-linked immunodeficiency. J. Exp. Med. 151, 853-862.
39. Stevens, R., Dichek, D., Keld, B., Heiner, D., 1983. IgG1 is the predominant subclass of in vivo and in vitro produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivery of inhibitory signals to anti-tetanus antibody-producing B-cells. J. Clin. Immunol. 3, 65-69.
40. Svennerholm, A.M., Hanson, L.A., Holmgren, J., Lindblad, B.S., Nilsson, B., Quereshi, F., 1980. Different secretory immunoglobiilin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect. Immun. 30, 427-430.
41. Sweeney, C.R., Benson, C.E., Whitlock, R.H., Meirs, D.A., Barningham, S.O., Whitehead, S.C., Cohen, D., 1989. Description of an epizootic and persistence of Streptococcus equi infections in horses. J. Am. Vet. Med. Assoc. 194, 1281-1286.
42. Timoney, J.F., 1993. Strangles. In: Traub-Dargatz, J.L. (Ed.), The Veterinary Clinics of North America: Equine Practice. Saunders, Philadelphia, PA, pp. 365-374.
43. Timoney, J.F., Eggers, D., 1985. Serum bactericidal responses to Streptococcus equi of horses following vaccination. Equine Vet. J. 17, 306-310.
44. Timoney, J.F., Guan, M., 1996. Characterisation of murine monoclonal antibodies recognising opsonic, mouse-protective, chaining and mucosally relevent epitopes on the M protein of Streptococcus equi subspecies equi. Res. Vet. Sci. 60, 76-81.
45. Timoney, J.F., Trachman, J., 1985. The immunologically reactive proteins of Streptococcus equi. Infect. Immun. 48, 29-38.
46. Timoney, J.F., Umbach, A., Boschwitz, J.E., Walker, J.A., 1994. Streptococcus equi subsp. equi expresses 2 M-like proteins including a homologue of the variable M-like protective protein of subsp. zooepidemicus. In: Plowright, W., Nakajima, H. (Eds.), Proceedings of seventh International Conference on Equine Infectious Diseases. R and W Publications, Newmarket, U.K., pp. 195-200.
47. Timoney, J.F., Walker, J., Zhou, M., Ding, J., 1995. Cloning and sequence analysis of a protective M-like protein gene from Streptococcus equi subsp. zooepidemicus. Infect. Immun. 63, 1440-1445.
48. Todd, K.G., 1910. Strangles. J. Comp. Pathol. Ther. 23, 212-229.
49. Wagner, D.K., Clements, M.L., Reimer, C.B., Snyder, M., Nelson, D.L., Murphy, B.R., 1987. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J. Clin. Microbiol. 25, 559-562.
50. Woolcock, J.B., 1975. Immunity to S. equi. Aust. Vet. J. 51, 554-559.
51. Zhang, W., Voice, J., Lachmann, P.J., 1995. A systemic study of neutrophil degranulation and respiratory burst in vitro by defined immune complexes. Clin. Exp. Immunol. 101, 507-514.